OrthoPediatrics Inc. (KIDS) Enterprise Value to EBITDA Ratio
OrthoPediatrics Corp. is a unique technological leader creating innovative implants for pediatric surgery and developing 3D planning. The business's current EV/EBITDA multiple demonstrates the company's valuation dynamics, where the 751.38 level serves as a critical benchmark. Stable management is effectively implementing pediatric innovations while maintaining strict R&D discipline. US-based production relies on close ties with the world's leading clinics, ensuring reliability within this narrow niche.
Comprehensive metric breakdowns and analytics for orthopediatrics.com (KIDS)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio OrthoPediatrics Corp.|KIDS - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity OrthoPediatrics|KIDS - Company Total Debt|Debts to Book Capitalization OrthoPediatrics Corp|KIDS - Long-Term Debt|Company Short-Term Debts OrthoPediatrics|Quick Ratio orthopediatrics.com
- financial results and valuation multiples details:
KIDS - Net Financial Result|Projected Future Earnings OrthoPediatrics Corp.|KIDS - Price to Earnings Ratio|Forward P/E Multiple OrthoPediatrics|KIDS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization OrthoPediatrics Corp|KIDS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months OrthoPediatrics|KIDS - Earnings per share for the trailing year|Quarterly EPS earnings growth orthopediatrics.com|KIDS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year OrthoPediatrics Corp.
Analysis of all company metrics:OrthoPediatrics Inc. KIDS
This ratio compares the total enterprise value, including net debt, with operating profitability, allowing for an assessment of the real value of assets without the influence of tax regimes and depreciation. By analyzing the EV/EBITDA multiple, an investor determines the efficiency of the capital-intensive innovations of OrthoPediatrics Corp. (KIDS) in creating specialized pediatric implants, separating the fundamental value of engineering developments from market speculation.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|ReWalk Robotics Ltd. (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Autonomix Medical (AMIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|BBLG: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Operating Income Before Depreciation Ratio BIOL|EV/EBITDA Multiple DYNT (Dynatronics)|Business Value to Operating Income Before Depreciation FNA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
